Autoimmunity: From the mosaic to the kaleidoscope

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 1-4

  Blank, Miri ^a   Gershwin, M Eric ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; HUMAN MONOCLONAL ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL IMMUNOLOGY; EDITORIAL; GOODPASTURE SYNDROME; HEMATOLOGY; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SPECIALIST; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; VASCULITIS; WOUND; HISTORY; HUMAN; ISRAEL;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; HISTORY, 21ST CENTURY; HUMANS; ISRAEL;

EID: 38049050759     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.015     Document Type: Editorial

References (27)

1. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
2. Andreoli L., Pregnolato F., Burlingame R., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
3. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
4. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology. J Autoimmun 30 (2008) 58-62
5. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
6. Leskovsek N., Mackay I.R., and Rose N.R. Cell damage and autoimmunity: A critical appraisal. J Autoimmun 30 (2008) 5-11
7. Nakanishi Y., Tsuneyama K., Fujimoto M., Thucydides L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
8. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
9. Praprotnik S., Snezna S.-S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
10. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
11. Shoenfeld Y., and Gershwin M. Autoimmunity: From the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
12. Borchers A.T., Selmi C., Cheema G., Keen C.L., Shoenfeld Y., and Gershwin M.E. Juvenile idiopathic arthritis. Autoimmun Rev 5 (2006) 279-298
13. Brandt D., and Gershwin M.E. Common variable immune deficiency and autoimmunity. Autoimmun Rev 5 (2006) 465-470
14. Chan A.T., Flossmann O., Mukhtyar C., Jayne D.R., and Luqmani R.A. The role of biologic therapies in the management of systemic vasculitis. Autoimmun Rev 5 (2006) 273-278
15. Chang X., Zheng P., and Liu Y. FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun Rev 5 (2006) 399-402
16. Chapman J. Thrombin in inflammatory brain diseases. Autoimmun Rev 5 (2006) 528-531
17. Chung L., and Fiorentino D. Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 5 (2006) 125-128
18. Damoiseaux J.G., and Tervaert J.W. From ANA to ENA: how to proceed?. Autoimmun Rev 5 (2006) 10-17
19. Deshmukh U.S., Bagavant H., and Fu S.M. Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev 5 (2006) 414-418
20. Doria A., Sarzi-Puttini P., and Shoenfeld Y. 2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005. Autoimmun Rev 5 (2006) 55-63
21. Duan B., and Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev 5 (2006) 403-408
22. Ichiki Y., Bowlus C.L., Shimoda S., Ishibashi H., Vierling J.M., and Gershwin M.E. T cell immunity and graft-versus-host disease (GVHD). Autoimmun Rev 5 (2006) 1-9
23. Knight A.K., and Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5 (2006) 156-159
24. Kong J.S., Teuber S.S., and Gershwin M.E. Potential adverse events with biologic response modifiers. Autoimmun Rev 5 (2006) 471-485
25. Stojanovich L. Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 5 (2006) 344-348
26. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: Highlighting a novel player in the autoimmunity scenario. J Autoimmun 29 (2007) 61-68
27. Lan R.Y., Mackay I.R., and Gershwin M.E. Regulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the border. J Autoimmun 29 (2007) 272-280